David Ege

Company: Seres Therapeutics

Job title: Chief Technology Officer and Execvtive Vice President - Process Development, Quality & Supply

Seminars:

Vowst – The CMC Journey from Idea to FDA Approval 9:00 am

How to develop an FMT product and identify a CDMO to manufacture an orally-dosed, spore-forming drug Challenges to adapt a multi-product facility to support handling of bacterial spores and the complexities behind process and analytical development The journey to Phase III through PAI readiness, inspection and ramp up to commercial manufacturingRead more

day: Conference Day One